Back

Watch Compare

BioScience Health Innovations, Inc.

Data quality: 100%

BHIC

OTC Technology Cloud & Data Services

$2.15

▼ $0.06 (-2.71%)

Mkt Cap: 24.44 M

Price

$2.15

Mkt Cap

24.44 M

Day Range

$2.15 — $2.15

52-Week Range

$0.52 — $52.00

Volume

300

Open $2.15

50D / 200D Avg

$3.48

38.17% below

50D / 200D Avg

$7.23

70.26% below

Quick Summary

Key Takeaways

Earnings grew 638.03% over the past year

ROE of 37.43% indicates high profitability

Generating 172,178.0 in free cash flow

P/E of 38.06 — premium valuation

ROIC of 27.55% — excellent capital efficiency

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)208.34%

Earnings (1Y)638.03%

FCF Growth (3Y)N/A

Quality

Return on Equity

37.43%

Above sector avg (1.81%)

ROIC27.55%

Net Margin11.29%

Op. Margin12.64%

Safety

Debt / Equity

N/A

Current RatioN/A

Interest CoverageN/A

Valuation

PE (TTM)

38.06

Above sector avg (-0.15)

P/B Ratio14.28

EV/EBITDA32.40

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Technology sector median (1058 peers)

Metric	Stock	Sector Median
P/E	38.1	-0.1
P/B	14.3	3.0
ROE %	37.4	1.8
Net Margin %	11.3	-0.5
Rev Growth 5Y %	—	7.2
D/E	—	0.4

All Fundamental Metrics

Growth
Revenue Growth (1Y)	208.34%	Revenue Growth (3Y)	208.53%
Earnings Growth (1Y)	638.03%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	5.69 M	Net Income (TTM)	642,090.0
ROE	37.43%	ROA	31.14%
Gross Margin	56.97%	Operating Margin	12.64%
Net Margin	11.29%	Free Cash Flow (TTM)	172,178.0
ROIC	27.55%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	N/A
Interest Coverage	N/A	Asset Turnover	2.76
Working Capital	N/A	Tangible Book Value	1.64 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	38.06	Forward P/E	N/A
P/B Ratio	14.28	P/S Ratio	4.30
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	32.40	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	0.70%
Market Cap	24.44 M	Enterprise Value	23.30 M
Per Share
EPS (Diluted TTM)	0.06	Revenue / Share	0.50
FCF / Share	0.02	OCF / Share	0.02
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	26.82%
SBC-Adj. FCF	N/A	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5.69 M	1.84 M	597,595.0	0.0	0.0
Net Income	642,090.0	87,000.0	-251,500.0	-83,208.0	-25,610.0
EPS (Diluted)	0.06	0.00	—	—	—
Gross Profit	3.24 M	1.31 M	484,407.0	—	—
Operating Income	719,051.0	87,000.0	-251,500.0	-91,921.0	-25,610.0
EBITDA	—	—	—	—	—
R&D Expenses	161,353.0	25,908.0	—	—	—
SG&A Expenses	2.21 M	1.15 M	706,257.0	91,921.0	25,610.0
D&A	—	—	—	—	—
Interest Expense	—	—	—	450.0	450.0
Income Tax	76,961.0	0.0	0.0	0.0	0.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	1.71 M	873,788.0	93,388.0	16,253.0	6,314.0
Total Liabilities	229,851.0	38,548.0	100,148.0	1,860.0	19,106.0
Shareholders' Equity	1.48 M	835,240.0	-6,760.0	14,393.0	-12,792.0
Total Debt	—	—	—	—	—
Cash & Equivalents	661,925.0	662,517.0	19,238.0	—	2,035.0
Current Assets	1.56 M	847,751.0	93,388.0	16,253.0	6,314.0
Current Liabilities	—	—	—	—	—